Recent Comments
- Bill on The Declaration of Pandemics
- Margaret McGregor on The Declaration of Pandemics
- admin on A Surgeon’s Story: Decision-making
- Margaret McGregor on A Surgeon’s Story: Decision-making
- LB on Has Bobby Kennedy’s campaign been infiltrated by intelligence operations?
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (18,020)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (16,185)
- New treatment paradigm for C. Diff colitis (14,855)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (14,814)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (14,278)
- How the FDA regulates compounding pharmacies (14,138)
- The Healthcare Channel hits 10 (13,677)
- The new CDC guidelines for prescribing opioid pain pills (9,158)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (8,690)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (8,385)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: FDA
Are the new PCSK9 cholesterol lowering drugs worth the high cost?
December 16, 2015- Interviewed by Steven E. Greer, MD
Posted in - Biotech, - NEJM, - Opinion, - Pharma, - Policy, Cardiology, CMS, FDA
Leave a comment
Martin Shkreli, CEO of Turing Pharmaceuticals, could be the Bernie Madoff of the drug industry
September 22, 2015- by Steven E. Greer, MD Making national news today was Martin Shkreli, the baby-faced, greasy-haired, disheveled-looking
Posted in - Biotech, - Pharma, Congress, FDA
Leave a comment
Stephen Colbert mocks the new “female viagra” flibanserin
September 20, 2015- Well, the real CBS news did an atrocious job covering this story, so the fake newsman
Actavis 1000% drug price hike: a case for healthcare reform
Update September 21, 2015- The Healthcare Channel was the first to report in 2009 on the business strategy of acquiring cheap generic drugs, cornering the market, then raising
Posted in - Biotech, - Generics, - Opinion, - Policy, CMS, Congress, FDA, Infectious disease
Leave a comment
The newly approved Edwards Lifesciences Sapien 3 aortic valve
July 5, 2015- Interviewed by Steven E. Greer, MD We interviewed William Suh, MD of UCLA about the newly approved Edwards Lifesciences Sapien
Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, UCLA
Leave a comment
Occluding the left atrial appendage to prevent stroke in A-fib
May 17, 2014- Thromboembolic stroke caused by atrial fibrillation is the primary reason patients are placed
Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford
Leave a comment
The FDA’s new Breakthrough status for new drug applications
May 24, 2013- Interviewed by Steven E. Greer, MD Janet Woodcock, MD,
Posted in - Pharma, FDA
Leave a comment
FDA official, William Maisel, pleads guilty to crime, keeps job
April 24, 2013 By Steven E. Greer, MD In July of 2012, the New York Times reported on an FDA scandal of the agency spying on internal
Posted in FDA
Leave a comment
The serious adverse events caused by topical testoserone
March 1, 2014
Posted in - Pharma, Dermatology, Diabetes and endocrinology, FDA
Leave a comment
FDA investigated by congress for spying on whistleblowers
Update February 26, 2014- Senator Grassley convened an oversight hearing in the senate, and also
Posted in Congress, FDA
Leave a comment
The FDA discusses Brilinta
February 4, 2014- The WSJ is reporting today on a Johns Hopkins doctor who filed a federal
Posted in - Pharma, Cardiology, FDA
Leave a comment
Why the lack of outrage over smoking depicted in film and television?
January 20, 2014 To Senators Dick Durbin, Richard Blumenthal, Sherrod Brown, and Edward Markey
Posted in - Opinion, Congress, FDA
Leave a comment
Laws governing genetic tests
December 19, 2013– Interviewed by Steven E. Greer, MD In Part 2 of our interview with Robert Klitzman, MD, from Columbia University, he discusses
Posted in Columbia, Congress, FDA, Genetics
Leave a comment
TAVI: Comparing CoreValve to Sapien
November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the recent pivotal data for the Medtronic CoreValve device,
Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford
Leave a comment
Interview with MannKind’s CEO, Al Mann, and CFO, Matt Pfeffer.
October 23, 2013- Interviewed by Steven E. Greer, MD The Healthcare Channel interviewed the CEO of MannKind, Al Mann, and the CFO, Matt Pfeffer.
FDA reviews the safety of Januvia, Byetta, and other GLP-1 diabetes drugs
Interviewed by Steven E. Greer, MD
Posted in - Pharma, FDA
Leave a comment
Renal denervation devices to treat hypertension
William O’Neill, MD of Henry Ford Hospital discusses renal denervation devices used to treat refractory hypertension. He is involved with the Medtronic device trials.
Posted in - Medical Devices, Cardiology, FDA, Henry Ford
Leave a comment
FDA official, William Maisel, pleads guilty to crime, keeps job
April 24, 2013 By Steven E. Greer, MD In July of 2012, the New York Times reported on an FDA scandal of the agency spying on internal
Posted in - Medical Devices, FDA
Leave a comment
Smartphone apps to be regulated and taxed as medical devices
March 26, 2013 Which smartphone apps will the FDA label as a medical device making them taxable tax under
Posted in - Medical Devices, Congress, FDA
Leave a comment
High fructose consumption and fatty liver disease
Manal F. Abdelmalek, MD, MPH, of the Duke Medical Center’s Division of Gastroenterology/Hepatology
Posted in Diabetes and endocrinology, Duke, FDA, Pediatrics
Leave a comment